Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention.

Literature DB >> 21821094

Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention.

John Q Trojanowski, Harald Hampel.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers

Year: 2011 PMID： 21821094 PMCID： PMC3575085 DOI： 10.1016/j.pneurobio.2011.07.004

Source DB: PubMed Journal: Prog Neurobiol ISSN： 0301-0082 Impact factor: 11.685

× No keyword cloud information.

29 in total

1. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

Authors: J L Price; J C Morris
Journal: Ann Neurol Date: 1999-03 Impact factor: 10.422

2. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.

Authors: Lon White; Brent J Small; Helen Petrovitch; G Webster Ross; Kamal Masaki; Robert D Abbott; John Hardman; Daron Davis; James Nelson; William Markesbery
Journal: J Geriatr Psychiatry Neurol Date: 2005-12 Impact factor: 2.680

3. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors: R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal: Ann Neurol Date: 1991-10 Impact factor: 10.422

4. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors: R Brookmeyer; S Gray; C Kawas
Journal: Am J Public Health Date: 1998-09 Impact factor: 9.308

5. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Authors: Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Michal Figurski; Els Coart; Kaj Blennow; Holly Soares; Adam J Simon; Piotr Lewczuk; Robert A Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal: Acta Neuropathol Date: 2011-02-11 Impact factor: 17.088

6. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

Authors: L E Hebert; L A Beckett; P A Scherr; D A Evans
Journal: Alzheimer Dis Assoc Disord Date: 2001 Oct-Dec Impact factor: 2.703

7. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Authors: T Gómez-Isla; R Hollister; H West; S Mui; J H Growdon; R C Petersen; J E Parisi; B T Hyman
Journal: Ann Neurol Date: 1997-01 Impact factor: 10.422

Review 8. Mild cognitive impairment as a diagnostic entity.

Authors: R C Petersen
Journal: J Intern Med Date: 2004-09 Impact factor: 8.989

9. Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Authors: Julie A Schneider; Zoe Arvanitakis; Woojeong Bang; David A Bennett
Journal: Neurology Date: 2007-06-13 Impact factor: 9.910

10. Prevalence of dementia in the United States: the aging, demographics, and memory study.

Authors: B L Plassman; K M Langa; G G Fisher; S G Heeringa; D R Weir; M B Ofstedal; J R Burke; M D Hurd; G G Potter; W L Rodgers; D C Steffens; R J Willis; R B Wallace
Journal: Neuroepidemiology Date: 2007-10-29 Impact factor: 3.282

12 in total

Review 1. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Authors: Kaj Blennow; Bruno Dubois; Anne M Fagan; Piotr Lewczuk; Mony J de Leon; Harald Hampel
Journal: Alzheimers Dement Date: 2014-05-03 Impact factor: 21.566

2. Senile Dementia from Neuroscientific and Islamic Perspectives.

Authors: Mohd Amzari Tumiran; Noor Naemah Abdul Rahman; Rohaida Mohd Saat; Ahmad Zuhdi Ismail; Wan Adriyani Wan Ruzali; Nurul Kabir Nurul Bashar; Durriyyah Sharifah Hasan Adli
Journal: J Relig Health Date: 2018-02

Review 3. Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.

Authors: S Lista; B Dubois; H Hampel
Journal: J Nutr Health Aging Date: 2015-02 Impact factor: 4.075

Review 4. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.

Authors: Harald Hampel; Sid E O'Bryant; José L Molinuevo; Henrik Zetterberg; Colin L Masters; Simone Lista; Steven J Kiddle; Richard Batrla; Kaj Blennow
Journal: Nat Rev Neurol Date: 2018-11 Impact factor: 42.937

5. Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.

Authors: Cassandra A DeMarshall; Eric P Nagele; Abhirup Sarkar; Nimish K Acharya; George Godsey; Eric L Goldwaser; Mary Kosciuk; Umashanger Thayasivam; Min Han; Benjamin Belinka; Robert G Nagele
Journal: Alzheimers Dement (Amst) Date: 2016-04-12

6. Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.

Authors: Spencer A W Lee; Luciano A Sposato; Vladimir Hachinski; Lauren E Cipriano
Journal: Alzheimers Res Ther Date: 2017-03-16 Impact factor: 6.982

7. Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson's Disease.

Authors: Hyunjung Baek; Hyun Il Jang; Hat Nim Jeon; Hyunsu Bae
Journal: Front Aging Neurosci Date: 2018-06-11 Impact factor: 5.750